Biotherapeutics Development Services

Functional and Predictive Assays for Biotherapeutics Development

‘Our predictive assays help you assess efficacy and toxicity of your compounds’

  • Efficacy

    Primary cell binding

    Primary cell activation

    Targeted killing

    Cell signaling

  • Toxicity



    Cytokine release syndrome

    Cytokine storm


Please Download our Brochure to find out more about our services for biotherapeutics development

HemoRANK - TKI Assays

For Ranking Myelotoxic Potential of New Tyrosine Kinase Inhibitors

The HemoRANK(TM) – TKI Assay Service Package Includes:

  • Testing of your novel TKI compound(s) in in vitro CFC assays in parallel with a panel of 6 standard TKIs with known levels of clinical myelotoxicity
  • Ranking of in vitro myelotoxicity of test TKI(s) compared to standards
  • Prediction of clinical myelotoxicity potential of test TKI(s)
  • Full written report with data interpretation and statistical analysis
  • Full confidentiality
  • Standardized pricing

Please Download our Brochure to learn more about service package

cellPrism® | Drug Development Platform

Using our predictive toxicology and immunology assays, let us help you with your program challenges:

  • Thrombocytopenia & Platelet Development
  • Antibody Testing
  • Severe Anemia & Red Blood Cell Development
  • Neutropenia & Myeloid/Neutrophil Development
  • Lymphopenia Development
  • Target Validation
  • Cytokine Storm Concerns
  • Immuno-Oncology and Immuno-Phenotyping

Please Download our Brochure to find out more about our cellPrism® drug development assays.